Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine

E-ISSN： 1349-7006|109|1|215-224

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 215-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 584-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1561-1567

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1714-1721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 611-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Cancer Science, Vol. 109, Iss. 1, 2018-01 ,pp. : 193-198

John Wiley & Sons Inc

Access to resources Recommend Favorite